Tenderwize
Wróć do wyszukiwania

Open-House Biologics Discount Contracts 2024-11 - Hepatitis B Immune Globulin (ATC Code J06BB04)

Techniker Krankenkasse·Hamburg, Germany·Deadline Oct 29, 2026 · 65 days left·Open·Supplies
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2024-11 - Hepatitis-B-Immunglobulin (ATC-Code J06BB04)

50/100

Ocena szansy

Needs reviewMedium complexity
SuppliesOpen
Skąd ta ocena?

Szansa

50 / 100

Złożoność

40 / 100

Czynniki ryzyka

No commitment from health insurers to purchase any quantity; actual uptake depends on pharmacy selections.

Subject to dispute resolution via social courts, not procurement chambers; legal uncertainty if classification as publi...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until Oct 2026
  • Conclusion of discount contracts for Hepatitis-B immune globulin (ATC J06BB04) with qualified pharmaceutical entrepreneurs
  • Open-house procedure with no exclusivity and no negotiation of terms
Pokaż pełne podsumowanie

Open-house procedure by German health insurers (Techniker Krankenkasse, HEK, hkk) to conclude discount contracts for Hepatitis-B immune globulin (ATC J06BB04) under §130a Abs. 8 SGB V. The procedure runs from 01.11.2024 to 31.10.2026, with eligibility for any qualified pharmaceutical entrepreneur meeting authorization and reliability criteria. Contracts are non-exclusive, no negotiations, and participation possible at any time during the term. No estimated value provided.

Ryzyka

No commitment from health insurers to purchase any quantity; actual uptake depends on pharmacy selections.

Subject to dispute resolution via social courts, not procurement chambers; legal uncertainty if classification as publi...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Must be a pharmaceutical entrepreneur according to §4 Abs. 18 AMG regarding the offered medicinal product
  • Must have a valid marketing authorization under §21 AMG or equivalent right to place on the market
  • Must have seat in Germany, EU, or EEA (§9 Abs. 2 AMG)

Zamawiający

Lokalizacja

Hamburg, DEU

Identyfikator

992-80116-93

Działalność

Health

Części (1)

LOT-0001

Open-House Biologics Discount Contracts 2024-11 - Hepatitis B Immune Globulin (ATC Code J06BB04)

Conclusion of discount contracts for Hepatitis-B immune globulin (ATC J06BB04) as an open-house procedure. No exclusivity, no negotiations, uniform conditions.

SuppliesEU fundedElectronic submission

Lokalizacja

DE600, Germany

Czas trwania

Oct 2024 - Oct 2026

Kategoria

Pharmaceutical products

Termin

Deadline Oct 29, 2026

Szczegóły zamówienia

Data publikacji
22 Sep 2024
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
569809-2024

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3